Condition
BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms
Total Trials
5
Recruiting
1
Active
2
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 4 (1)
Trial Status
Completed2
Active Not Recruiting1
Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04801381Not ApplicableActive Not RecruitingPrimary
WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80 - 180mL) in Benign Prostatic Hyperplasia
NCT05130918Not ApplicableCompletedPrimary
Efficacy of Mictalase® After ThuLEP
NCT03605745Not ApplicableTerminated
Minimally Invasive Prostatic Vapor Ablation for the Treatment of BPH in Large Prostates (Rezūm XL)
NCT04599283Not ApplicableCompleted
BE Technologies Mobile Uroflowmetry Validation Study
NCT04102566Phase 4Recruiting
Optimizing Pain Control in Transurethral Resection of the Prostate
Showing all 5 trials